scispace - formally typeset
A

Antonia Anna Lukito

Researcher at University of Pelita Harapan

Publications -  37
Citations -  945

Antonia Anna Lukito is an academic researcher from University of Pelita Harapan. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 21 publications receiving 513 citations.

Papers
More filters
Journal ArticleDOI

Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression.

TL;DR: Hypertension was associated with increased composite poor outcome, including mortality, severe COVID-19, acute respiratory distress syndrome (ARDS), need for intensive care unit (ICU) care and disease progression in patients with CO VID-19.
Journal ArticleDOI

Clinical frailty scale and mortality in COVID-19: A systematic review and dose-response meta-analysis.

TL;DR: In this paper, the authors performed a systematic literature search from several electronic databases up until 8 September 2020 and reported that increase in CFS was associated with increase in mortality in a linear fashion, and the potential for a nonlinear relationship based on ORs of each quantitative clinical frailty scale was examined using restricted cubic splines with a three-knots model.
Journal ArticleDOI

Body mass index and outcome in patients with COVID-19: A dose-response meta-analysis.

TL;DR: A meta-analysis of the dose-response relationship between body mass index (BMI) and poor outcome in patients with COVID-19 demonstrated that obesity was associated with composite poor outcome.
Journal ArticleDOI

Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.

TL;DR: Elevated NT-proBNP level was associated with increased mortality in COVID-19 pneumonia and summary receiver operating characteristic curve analysis demonstrates an area under curve of 0.90.
Journal ArticleDOI

Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19.

TL;DR: It was revealed that COPD and smoking were associated with poor outcomes in patients with COVID-19, and current smokers were at higher risk of composite poor outcomes.